Results 1-10 of 22.
 |   | 
JRC N°Publication YearTitleAuthor(s), Editor(s), Other Contributor(s)
JRC970482016Radioimmunothérapie alpha Principes et intérêts en immunité antitumoraleMENAGER J; GORIN J; FICHOU Nolwenn; GOUARD S.; MORGENSTERN Alfred; BRUCHERTSEIFER Frank; DAVODEAU F; KRAEBER BODÉRÉ F; CHEREL M.; GASCHET J; GUILLOUX Yannick
JRC1030832016Dual Isotope Labeled Multimeric PSMA LigandsWURZER A; SEIDL C.; MORGENSTERN Alfred; BRUCHERTSEIFER Frank; WESTER Hans-Jürgen; NOTNI Johannes
JRC911612016Nanoconjugation of PSMA-Targeting Ligands Enhances Perinuclear Localization and Improves Efficacy of Delivered Alpha-Particle Emitters against Tumor Endothelial AnaloguesZHU Charles; BANDEKAR Amey; SEMPKOWSKI Michelle; BANERJEE Sangeeta Ray; POMPER Martin; BRUCHERTSEIFER Frank; MORGENSTERN Alfred; SOFOU Stavroula
JRC1001962016Ac-225-PSMA617 - a single center experience of 40 patients receiving PSMA-targeted alpha therapyKRATOCHWIL Clemens; GIESEL Frederik; BRUCHERTSEIFER Frank; RIUS MONTRAVETA MARIA; APOSTOLIDIS CHRISTOS; HABERKORN Uwe; MORGENSTERN Alfred
JRC1003482016Alpha therapy with 213Bi-DOTA-substance P in recurrent glioblastoma multiformeKROLICKI Leszek; MORGENSTERN Alfred; KUNIKOWSKA Jolanta; KOZIARA H; KROLICKI B; JAKUCINSKI M; PAWLAK Dariusz; APOSTOLIDIS CHRISTOS; BRUCHERTSEIFER Frank
JRC828652016A fully human antibody to gp41 selectively eliminates HIV-infected cells that transmigrated across a model human blood brain barrierMCFARREN A; LOPEZ L; WILLIAMS D; VEENSTRA Mike; BRYAN R. A.; GOLDSMITH Aliza; MORGENSTERN Alfred; BRUCHERTSEIFER Frank; ZOLLA-PAZNER S.; GORNY M.k.; EUGENIN E; BERMAN J; DADACHOVA E.
JRC1009552016Ac-225-PSMA617 PSMA-gerichtete Alpha-Strahler-Therapie des metastasierten ProstatakarzinomsKRATOCHWIL Clemens; BRUCHERTSEIFER Frank; GIESEL Frederik; RIUS MONTRAVETA MARIA; APOSTOLIDIS CHRISTOS; HABERKORN Uwe; MORGENSTERN Alfred
JRC984152016Targeted Radiolabeled Compounds in Glioma TherapyCORDIER D.; KROLICKI Leszek; MORGENSTERN Alfred; MERLO A.
JRC1018002016Effective treatment of ductal carcinoma in situ with a HER-2-targeted alpha-particle emitting radionuclide in a preclinical model of human breast cancerYOSHIDA Takahiro; JIN Kideok; SONG H.; PARK Sunju; HUSO D. L.; ZHANG Z.; LIANGFENG Han; ZHU Charles; BRUCHERTSEIFER Frank; MORGENSTERN Alfred; SGOUROS G.; SUKUMAR Saraswati
JRC1000452016Influence of tumour size on the efficacy of targeted alpha therapy with 213Bi-[DOTA0,Tyr3]-octreotateCHAN Ho Sze; KONIJNENBERG M.w.; DE BLOIS Erik; KOELEWIJN S.j.; BAUM Richard; MORGENSTERN Alfred; BRUCHERTSEIFER Frank; BREEMAN Wouter; DE JONG Marion